Status:
WITHDRAWN
Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
Lead Sponsor:
Pinnacle Biologics Inc.
Conditions:
Esophageal Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Three main adverse reactions, namely photosensitivity (reaction that is similar to sunburn), oesophageal stenosis (narrowing or closure of the food pipe), perforation of the treated area (a tear or pu...
Detailed Description
Patients will be enrolled in the registry upon injection of the porfimer sodium. During normal medical examination, criteria for entry onto the registry will be verified to confirm eligibility, and me...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo PDT with Photofrin
- Patients must have the mental, literate, and legal ability to give a written informed consent, which must comply with the International Conference on Harmonization (ICH) guidelines and local requirements.
Exclusion
- Patients treated with Photosan®
- Patients being treated with any investigational drug or participating in any interventional studies, with the exception of investigational photoprotection measures.
- Patients who are unable or unwilling to complete the follow-up evaluations required for the registry.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01203163
Last Update
May 9 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.